Postdoctoral Fellow - Computational Biology & Medicine - Jhunjhunwala Lab
![]() | |
![]() United States, California, South San Francisco | |
![]() | |
The Position
A healthier future. It's what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That's what makes us Genentech. Are you a highly passionate computational biologist looking to make a significant impact in cancer immunology? Join Genentech's Computational Sciences Center of Excellence as a Postdoctoral Fellow, where you'll conduct cutting-edge research at the intersection of computational biology and oncology. This position offers a unique opportunity to be jointly mentored by experts in our Computational Biology and Medicine department and our Oncology Research organization. The Role: Primarily focused on tumor antigens, T cell receptor (TCR) and antigen interactions and their crucial role in anti-cancer immune responses. You'll leverage your strong background in computational biology, machine learning, and structural biology to tackle challenging scientific questions. Your responsibilities will include, but are not limited to:
This is a fantastic opportunity to contribute to world-class science in a leading biotechnology company. Who you are:
For information about the Jhunjhunwala Lab at Genentech, please go to: https://www.gene.com/scientists/our-scientists/suchit-jhunjhunwala Relevant publications: Thrift, W. J. et al. Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity. Briefings in Bioinformatics 25 (2024). Thrift, W. J. et al. HLApollo: A superior transformer model for pan-allelic peptide-MHC-I presentation prediction, with diverse negative coverage, deconvolution and protein language features. bioRxiv (2022) doi:10.1101/2022.12.08.519673. Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 1-15 (2021) doi:10.1038/s41568-021-00339-z. Chen, J. et al. In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales. Brief Bioinform bbaa223- (2020) doi:10.1093/bib/bbaa223. Capietto, A.-H. et al. Mutation position is an important determinant for predicting cancer neoantigens. J Exp Medicine 217, (2020). Kong, Y. et al. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nat Commun 10, 5228 (2019). Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572-576 (2014). Postdoc Program The Genentech Postdoc Program provides access to world-class seminars, professional development workshops, and networking opportunities. The expected salary range for this position based on the primary location of California is $110,000 to $120,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. This position also qualifies for the benefits detailed at the link provided below. Benefits Relocation benefits are available for this job posting. #LI-PL1 #postdoc Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. |